GGrantIndex
Sort

78,016 grants matching breast cancer

Mechanisms Underlying Replication Stress And Genome Instability Upon BRCA2 Deficiency

$712,077
Shailja Pathania · University Of Massachusetts Boston · R01 · FY2025 · CA

The Emphysematous Microenvironment Promotes Lung Tumorigenesis and Progression

$712,065
John J Reilly · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · HL

Promoting Breast Cancer Screening in Non-Adherent Women

$712,044
Roger S Luckmann · Univ Of Massachusetts Med Sch Worcester · R01 · FY2009 · CA

Mechanobiology of Acinar Stability

$712,037
Valerie Marie Weaver · University Of California Berkeley · U54 · FY2010 · CA

Streamlined Template Preparation for Advanced Sequencing Methods

$712,037
Steven Jeffrey Gordon · Intelligent Bio-Systems, Inc. · R44 · FY2008 · HG

COMMUNITY TRIAL TO INCREASE CANCER SCREENING ADHERENCE

$711,900
Rand Corporation · R01 · FY2000 · CA

Role of FSH in postmenopausal obesity and breast cancer

$711,888
Jennifer Wright Bea · University Of Arizona · R01 · FY2024 · CA

The Symptom Experience, Management and Outcomes According to Race and Social Determinants of Health (SEMOARS) during Breast Cancer Chemotherapy

$711,829
Margaret Q Rosenzweig · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · MD

LIGHT-ACTIVATED GENE EXPRESSION IN SINGLE CELLS WITHIN TISSUE

$711,684
Robert H Singer · Albert Einstein College Of Medicine · R01 · FY2008 · GM

Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma

$711,607
Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

North Shore CCOP

$711,448
Vincent P Vinciguerra · Feinstein Institute For Medical Research · U10 · FY2013 · CA

Lifestyle and Molecular Factors of Bone Health in Breast Cancer Survivors

$711,417
Marilyn L Kwan · Kaiser Foundation Research Institute · R01 · FY2012 · CA

MDC1: central regulator of estrogen receptor function and therapy response in lobular carcinoma

$711,413
Matthew J Sikora · University Of Colorado Denver · R01 · FY2025 · CA

GENOME-WIDE ASSOCIATION STUDY ON BREAST CANCER

$711,371
Ross Prentice · · N01 · FY2007 · WH

Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity

$711,323
Sharon S Evans · Roswell Park Cancer Institute Corp · R01 · FY2021 · CA

Using MRI and circulating tumor DNA to improve the interpretation of response to immunotherapy and targeted therapy in CNS metastases

$711,319
Elizabeth Gerstner · Massachusetts General Hospital · R01 · FY2020 · CA

The effects of aromatase inhibition in older men with hypogonadism

$711,241
Chee W Chia · National Institute On Aging · ZIA · FY2015 · AG

Development of a platform for spatial functional genomics

$711,098
Brian D Brown · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · AT

Targeting 6-Phosphofructo-2-Kinase to increase efficacy of CDK4/6 Inhibitors

$711,007
Yoannis Imbert-Fernandez · University Of Louisville · R37 · FY2025 · CA

The Genetics of Susceptibility to Mouse Plasma Cell Tumors

$711,004
Beverly Mock · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Environmental and social determinants of mammographic features

$710,995
Francine Laden · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2025 · ES

Functional consequences of cancer mutations

$710,952
Chris Sander · Sloan-Kettering Inst Can Research · R01 · FY2010 · CA

Improved Metallofullerene MRI Contrast Agent for Cancer Diagnosis

$710,917
Zhiguo Zhou · Luna Innovations, Inc. · U44 · FY2014 · CA

Translating Behavioral Interventions for Health Disparity Populations

$710,893
Anna Maria Napoles · National Institute On Minority Health And Health Disparities · ZIA · FY2021 · MD

Prevention of Heart Failure induced by Doxorubicin with Early Administration of Dexrazoxane

$710,737
Hui-Ming Chang · Univ Of Arkansas For Med Scis · R01 · FY2023 · HL